补铁治疗对血清铁水平下降的慢性阻塞性肺疾病患者生活质量影响  

The impact of iron therapy on iron decreased chronic obstructive pulmonary disease patients

作　　者：李元广[1] 钟定[1] 黄彩霞[1] 

机构地区：[1]深圳市宝安区人民医院呼吸内科,广东深圳518101

出　　处：《中国医学前沿杂志（电子版）》2014年第7期45-47,共3页Chinese Journal of the Frontiers of Medical Science(Electronic Version)

基　　金：2012年深圳市宝安区科技局课题(2012018)

摘　　要：目的探讨补铁治疗对血清铁水平下降(<8.95μmol/L)的轻、中度慢性阻塞性肺疾病(COPD)患者生活质量的影响。方法将本院收治的血清铁水平下降的轻、中度COPD患者60例随机分为对照组与治疗组,每组各30例,对照组患者给予常规治疗(吸入噻托溴铵、口服氨茶碱、肺康复治疗等),治疗组患者在此基础上加用补铁治疗。观察治疗1年后两组患者血清铁、COPD评估测试(CAT)评分变化。结果治疗组患者经补铁治疗1年后血清铁水平显著升高,CAT评分改善明显,而对照组患者无明显改变。结论 0.1%血清铁水平下降(<8.95μmol/L)的轻、中度COPD患者,经补铁1年治疗后可以提高CAT评分,改善患者生活质量。Objective To explore the effect of iron therapy on serum iron decreased（ 〈8.95 μmol/L） with mild to moderate chronic obstructive pulmonary disease on quality of life. Method Serum iron decreased mild to moderate chronic obstructive pulmonary disease patients 60 cases were randomly divided into the experiment group（n = 30） and the control group（n = 30）; the control group received conventional treatment; the experiment group received additional iron therapy. The COPD assessment test（CAT） were recorded and compared before and after one year treatment between two groups. Result The CAT score and serum iron were improved significantly in experiment group after one year treatment, which were not seen in control group. Conclusion The iron therapy is effective in improve CAT and quality of life to iron decreased（〈 8.95 μmol/L） mild to moderate COPD patients.

关 键 词：慢性阻塞性肺疾病 血清铁 COPD评估测试 

分 类 号：R563.9[医药卫生—呼吸系统]